RISK WARNING: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74% and 89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
RISK WARNING: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
Trusted Trading Platform
Free account
Worldwide Trading
Portfolio Management
ChatGPT Image 6 mei 2026, 14_20_52

GlaxoSmithKline                      LSE London

GSK PLC (GSKxlon) is a British multinational biopharmaceutical company headquartered in London. The company researches, develops, manufactures and markets vaccines, specialty medicines and general medicines, with a strategic focus on infectious diseases, HIV, oncology and immunology. Key products include Shingrix, Arexvy, Trelegy Ellipta and the HIV portfolio through ViiV Healthcare. GSK operates in more than 75 countries. It is a major constituent of the FTSE 100 index on the London Stock Exchange and is also listed on the NYSE. GSK is one of the world's largest pharmaceutical and vaccines companies and a leading developer of preventive vaccines. 

 826828 symbol info
 
 


 
Top stories by TradingView
 Technical analysis for ZEG
 
826828 chart

Start trading
GlaxoSmithKline  now

At In2Markets, we offer unique strategies designed to align with your goals and adapt to changing market conditions. Our team will provide you with real-time support and expert insights to answer your question in a quick and personal way. Whether you’re trading or managing your portfolio, we combine innovation with a personalized approach to ensure you stay ahead.

Update I2M Telefoon (1)